A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx

NCT01140178 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Dysplasia
Carcinoma of the Oral Cavity
Carcinoma of the Oropharynx

Interventions

DRUG: HPPH

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]